Jump to content

PNCK

From Wikipedia, the free encyclopedia
PNCK
Identifiers
AliasesPNCK, BSTK3, CaMK1b, pregnancy up-regulated nonubiquitous CaM kinase
External IDsOMIM: 300680; MGI: 1347357; GeneCards: PNCK
Enzyme activity
EC #BRENDAExPASyKEGGMetaCyc
2.7.11.17↗↗↗↗
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001199351
NM_001199352
NM_012040

RefSeq (protein)

NP_001186280
NP_001186281
NP_036170

Location (UCSC)Chr X: 153.67 – 153.69 MbChr X: 72.7 – 72.7 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Pregnancy up-regulated nonubiquitous CaM kinase (PNCK), also called Calcium/calmodulin-dependent protein kinase type 1B (CAMKIβ), is an enzyme that in humans is encoded by the gene PNCK.[5][6] As a calcium/calmodulin-dependent protein kinase (CAMK), this enzyme acts as a second messenger involved in calcium-triggered signaling.[5] The protein PNCK is predicted to phosphorylate (add phosphates to) CAMK1, CREB1, and SYN1.[5]

Medical significance

[edit]

PNCK, like other members of the CAMKI family, is frequently over-expressed in specific cancers.[6] PNCK specifically is overexpressed in certain types of breast cancer, and in clear renal cell carcinoma compared to benign tissue.[6] Its expression has also correlated with the prognosis of acute myeloid leukaemia.[6]

References

[edit]
  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000130822 – Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000002012 – Ensembl, May 2017
  3. ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. 1 2 3 "Calcium/calmodulin-dependent protein kinase type 1B". uniprot.org. UniProt consortium. Retrieved 2026-10-16.
  6. 1 2 3 4 Brzozowski JS, Skelding KA (2019-01-07). "The multi-functional calcium/calmodulin stimulated protein kinase (CaMK) family: emerging targets for anti-cancer therapeutic intervention". Pharmaceuticals. 12 (1): 8. doi:10.3390/ph12010008. PMC 6469190. PMID 30621060.